Silence Therapeutics Plc (SLNCF)

1.06 0.00 (0.00%) USD  |  OTCM  |  May 29, 16:00
More

Silence Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Compass Pathways Plc Upgrade
HemoGenyx Pharmaceuticals Plc Upgrade